Trial Profile
Amelioration of Adverse Ocular Side Effects of Glaucoma Medications in Glaucoma Patients Using Topical GL101 - Proof of Concept, Safety, and Efficacy Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Mar 2023
Price :
$35
*
At a glance
- Drugs GL 101 (Primary)
- Indications Eye disorders
- Focus Adverse reactions; Proof of concept
- Sponsors Glia LLC.
- 23 Mar 2023 Status changed from active, no longer recruiting to completed.
- 29 Jul 2019 Planned End Date changed from 1 Sep 2016 to 30 Dec 2019.
- 29 Jul 2019 Status changed from recruiting to active, no longer recruiting.